Glycobiology Market is slated to grow at a gracious rate of 13%, reaching US$ 3.5 Bn by the year 2030

Glycobiology Market 2022

Glycobiology Market to Expand at 13% CAGR through 2030; Priority of Tackling COVID-19 Outbreak Impeding Market Progress. The global glycobiology market is expected to expand at an impressive CAGR of nearly 13% from 2020 to 2030, and reach a valuation of around US$ 3.5 Bn by the end of 2030, according to a new report by Persistence Market Research (PMR).

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/4769

With value-oriented approach being the need of the hour, the healthcare vertical is likely to go the technologically advanced way in the next 10 years. With Big Data, AI comprising these advancements, the healthcare vertical is bound to create greater strides going forward.

Extensive research related to carbohydrate molecules in various fields such as marine science and food & beverages is expected to fuel the growth of the global glycobiology market over the period of 2020 to 2030. With most stakeholders present in North America, the market in the region will hold sway throughout the forecast period.

Company Profiles:

Merck KGaA
Bio-Techne Corporation
User Corporation
Thermo Fisher Scientific, Inc.
Shimadzu Corporation
ProZyme Inc.
NEB Inc.
Agilent Technologies
New England Biolabs
Takara Bio
Waters Corporation
Danaher Corporation

Request For Customization@https://www.persistencemarketresearch.com/request-customization/4769

Key Takeaways from Glycobiology Market Study

On the basis of product, the enzymes segment is expected to dominate the market through the forecast period, and is anticipated to be the most lucrative segment. Due to high adoption of enzymes to conduct various research initiatives, this segment is expected to witness high incremental opportunity, globally.

On the basis of application, the drug discovery and development segment is expected to dominate the market, and is anticipated to be the most lucrative segment over the forecast period.

On the basis of end user, the biopharmaceutical companies segment is expected to account for the highest revenue share in the global glycobiology market, and is expected to witness the fastest growth over the forecast period. Factors such as increasing demand for novel drug development, especially for chronic diseases such as cancer and diabetes, are expected to boost revenue share contribution from biopharmaceutical companies. Research laboratories are also expected to register significant growth during the forecast period.

North America will lead the growth of the global glycobiology market through 2030, followed by the market in Europe.

"Due to the COVID-19 pandemic, industrial and academic research related to cancer and diabetes has slowed down, which will slow down the growth of the glycobiology market to some extent in the near term," says a PMR analyst.

What Else is in the Report?

Persistence Market Research offers a unique perspective and actionable insights on the glycobiology market in its latest study, presenting historical demand assessment of 2015-2019 and projections for the years 2020-2030. Research of this report has been done based on segmentation into product (instruments, enzymes, consumables, and reagent kits), enzyme (galactosidases, glcnac transferases, and others), application (drug discovery and development, diagnostic applications, industrial applications, therapeutic applications, and others), and end user (biopharmaceutical companies, research laboratories, hospitals, diagnostic centers, contract research organizations, biotechnology industries, academic institutes, and others), across seven key regions of the world.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/4769

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Araia, South Africa etc.)

Related Reports:

Renal Anemia Treatment Market -https://www.persistencemarketresearch.com/market-research/renal-anemia-treatment-market.asp

The report on Renal Anemia Treatment further projects significant growth potential with average year-on-year growth rate pegged at 7.5% over the period of 2018-2026.

Emergency Contraceptive Pills Market -https://www.persistencemarketresearch.com/market-research/emergency-contraceptive-pills-market.asp

Global Emergency contraceptive pills market to reach US$ 1,230 million, and is expected to exhibit sluggish growth and reflect less than 3% CAGR during 2017-2022.

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.